Avid Bioservices (CDMO) Reports Q2 EPS of $0.06

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. STZ
3. APLD
4. CRGY
5. PEP
6. DVN
7. ANGO
8. RMR
9. LULU
10. SPCX

Go back to Avid Bioservices (CDMO) Reports Q2 EPS of $0.06

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments

September 1, 2020 4:05 PM EDT

-- Recorded First Quarter Revenue of $25.4 Million --

-- Signed Three New Customers and Project Expansion Orders with Current Customers for $20 Million --

-- Backlog of $60 Million at Quarter-End --

TUSTIN, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (NASDAQ: CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies,... More